Company Profiles

driven by the PitchBook Platform

Antegrin Therapeutics

Description

Developer of compounds to treat lung disease. The company is developing compounds for the treatment of human fibrotic disease, initially targeting idiopathic pulmonary fibrosis, a progressive life-threatening condition.

2012

Founded

M&A

Status

Merger of Eq.

Latest Deal Type

$696k

Total Amount Raised

Description

Developer of compounds to treat lung disease. The company is developing compounds for the treatment of human fibrotic disease, initially targeting idiopathic pulmonary fibrosis, a progressive life-threatening condition.

Website:

www.antegrin.com

Ownership Status

Acquired/Merged

Financing Status

Formerly VC-Backed

Primary Industry

Therapeutic Devices

Other Industries

Other Healthcare

Primary Office

4320 Forest Park Avenue Suite 304 Saint Louis, MO 63108United States +1 (314) 932-4032
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Antegrin Therapeutics's full profile, request a free trial.

Antegrin Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Antegrin Therapeutics Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Peter RuminskiCo-Founder & Scientific Advisor
Robert Karr MDPresident, Chief Executive Officer & Board Member
George Capps IIDirector, Business Development
Rajesh Devraj Ph.DChairman
Peter Ruminski Co-Founder & Scientific Advisor
Robert Karr MD President, Chief Executive Officer & Board Member
George Capps II Director, Business Development
Rajesh Devraj Ph.D Chairman

Antegrin Therapeutics Board Members (5)

NameRepresentingRoleSinceContact
Info
David Griggs Ph.DIndalo TherapeuticsCo-Founder & Board Member000 0000
Michael Yeadon Ph.DSelfBoard Member000 0000
Rajesh Devraj Ph.DSelfChairman000 0000
Robert Karr MDSelfPresident, Chief Executive Officer & Board Member000 0000
Thomas Cirrito Ph.DSelfBoard Member000 0000
David Griggs Ph.D Co-Founder & Board Member Indalo Therapeutics
Michael Yeadon Ph.D Board Member Self
Rajesh Devraj Ph.D Chairman Self
Robert Karr MD President, Chief Executive Officer & Board Member Self
Thomas Cirrito Ph.D Board Member Self
Request full access to PitchBook